Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-24 @ 3:22 PM
NCT ID:
NCT00003092
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven nonhematologic malignancy
PATIENT CHARACTERISTICS:
Age:
* 55 and over
Performance status:
* Zubrod 0-2
Life expectancy:
* Not specified
Hematopoietic:
* Granulocyte count at least 1,500/mm3
* Platelet count at least 100,000/mm3
Hepatic:
* Bilirubin less than 1.5 mg/dL
* SGOT less than 2.0 times upper limit of normal (ULN)
Renal:
* Creatinine no greater than 1.5 times ULN
Cardiovascular:
* No uncontrolled or severe cardiovascular disease
Other:
* No serious intercurrent medical illnesses that in the judgement of the investigator compromise patient care
* No psychiatric conditions that would preclude study
* No requirement for antibiotics for active acute infection
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* At least 4 weeks since prior chemotherapy (6 weeks for nitrosoureas or mitomycin)
* No more than one prior chemotherapy regimen allowed
* No prior paclitaxel allowed
Endocrine therapy:
* Not specified
Radiotherapy:
* At least 4 weeks since prior radiation therapy
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Study:
NCT00003092
Study Brief:
Protocol Section:
NCT00003092